Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials

Authors:

Abstract
No abstract available
Funding Information
  • Roche
  • Gilead Sciences
  • Bristol-Myers Squibb

This publication has 25 references indexed in Scilit: